Harrow Health

-$0.04 (-0.48%) As of 7:03 PM UTC today

Why Robinhood?

You can buy or sell Harrow Health and other stocks, options, and ETFs commission-free!

About HROW

Harrow Health, Inc. engages in the development, production, and sale of innovative medications. It operates through the Pharmaceutical Compounding and Pharmaceutical Drug Development segments.

CEO
Mark L. Baum
Employees
125
Headquarters
Nashville, Tennessee
Founded
2006

HROW Key Statistics

Market Cap
240.61M
Price-Earnings Ratio
23.16
Dividend Yield
—
Average Volume
136.32K
High Today
$8.40
Low Today
$8.34
Open Price
$8.37
Volume
176.19K
52 Week High
$11.24
52 Week Low
$4.65

HROW News

BenzingaJun 17

Looking Into Harrow Health's Return On Capital Employed

Harrow Health (NASDAQ:HROW) posted a 7.77% decrease in earnings from Q4. Sales, however, increased by 5.81% over the previous quarter to $15.44 million. Despite

HROW Earnings

-$0.50
-$0.23
$0.05
$0.32
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure